NCCN Guidelines® Insights - Breast Cancer, Version 3.2018
These NCCN Guidelines Insights highlight the updated recommendations for use of multigene assays to guide decisions on adjuvant systemic chemotherapy therapy for women with hormone receptor-positive, HER2-negative early-stage invasive breast cancer.
  • Breast Cancer
  • Monograph/Journal Supplement
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • AAPA Category 1 CME credit
  • Participation